Oncolytic viruses: a new class of immunotherapy drugs
Howard L. Kaufman(Rutgers, The State University of New Jersey), Andrew Zloza(Rutgers, The State University of New Jersey)
Cited by 1,614
Related Papers
Clinical landscape of oncolytic virus research in 2020
|Journal for ImmunoTherapy of Cancer|2020|357
Intratumoral injection of the seasonal flu shot converts immunologically cold tumors to hot and serves as an immunotherapy for cancer
|Proceedings of the National Academy of Sciences|2019|191